The Cooper Companies, Inc. Common Stock COO
Analyst Ratings
- Consensus
- Hold — 5 Buy · 9 Hold · 1 Sell (15 analysts)
- Avg. Price Target
- $71.21 (+25.1% upside)
Key Stats
- Today's Range
- $56.72 – $57.69
- 50-Day Range
- $51.01 – $78.11
- 52-Week Range
- $51.01 – $89.83
- Volume
- 3.31 million shs
- Average Volume
- 4.32 million shs
- Market Cap
- $10.92 billion
- P/E Ratio
- —
- Dividend Yield
- 0.11%
Dividend
- Dividend Yield
- 0.11%
- Annual Dividend
- $0.06
- Payout Ratio
- —
- Ex-Dividend Date
- 2023-07-26
Short Interest
- Short Interest
- 0.66%
- Days to Cover
- 3.64
About The Cooper Companies, Inc. Common Stock
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Related Stocks
Compare head-to-head: COO vs WRBY·COO vs STAA·COO vs RXST
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.